请输入您要查询的百科知识:

 

词条 Serotonin releasing agent
释义

  1. Examples and use of SRAs

  2. List of SSRAs

      Pharmaceutical drugs    Research chemicals  

  3. See also

  4. References

  5. Further reading

A serotonin releasing agent (SRA) is a type of drug that induces the release of serotonin into the neuronal synaptic cleft. A selective serotonin releasing agent (SSRA) is an SRA with less significant or no efficacy in producing neurotransmitter efflux at other types of monoamine neurons.[1]

SSRAs have been used clinically as appetite suppressants, and they have also been proposed as novel antidepressants and anxiolytics with the potential for a faster onset of action and superior efficacy relative to the selective serotonin reuptake inhibitors (SSRIs).[2]

A closely related type of drug is a serotonin reuptake inhibitor (SRI).

Examples and use of SRAs

Amphetamines like MDMA, MDEA, MDA, and MBDB, among other relatives (see MDxx), are recreational drugs termed entactogens. They act as serotonin-norepinephrine-dopamine releasing agents (SNDRAs) and also agonize serotonin receptors such as those in the 5-HT2 subfamily. Fenfluramine, chlorphentermine, and aminorex, which are also amphetamines and relatives, were formerly used as appetite suppressants but were discontinued due to concerns of cardiac valvulopathy. This side effect has been attributed to their additional action of potent agonism of the 5-HT2B receptor. The designer drug 4-methylaminorex, which is an SNDRA and 5-HT2B agonist, has been reported to cause this effect as well.

Many tryptamines, such as DMT, DET, DPT, DiPT, psilocin, and bufotenin, are SRAs as well as non-selective serotonin receptor agonists.[3] These drugs are serotonergic psychedelics, which is a consequence of their ability to activate the 5-HT2A receptor. αET and αMT, also tryptamines, are SNDRAs and non-selective serotonin receptor agonists that were originally thought to be monoamine oxidase inhibitors and were formerly used as antidepressants.[3] They have since been discontinued and are now encountered solely as recreational drugs.

Indeloxazine is an SRA and norepinephrine reuptake inhibitor that was formerly used as an antidepressant, nootropic, and neuroprotective.

List of SSRAs

Pharmaceutical drugs

  • Chlorphentermine (Apsedon, Desopimon, Lucofen)
  • Cloforex (Oberex) (prodrug of chlorphentermine)
  • Dexfenfluramine (Redux) (enantiomer of fenfluramine)
  • Etolorex (prodrug of chlorphentermine; never marketed)
  • Fenfluramine (Pondimin, Fen-Phen)
  • Flucetorex (related to chlorphentermine; never marketed)
  • Indeloxazine (Elen, Noin) (non-selective; discontinued)
  • Levofenfluramine (enantiomer of fenfluramine)
  • Carbamazepine (Equetro, Epitol, and many other variations)

Research chemicals

  • Amiflamine (FLA-336)
  • Viqualine (PK-5078)
  • 2-Methyl-3,4-methylenedioxyamphetamine (2-Methyl-MDA)
  • 3-Methoxy-4-methylamphetamine (MMA)
  • 3-Methyl-4,5-methylenedioxyamphetamine (5-Methyl-MDA)
  • 3,4-Ethylenedioxy-N-methylamphetamine (EDMA)
  • 4-Methoxyamphetamine (PMA)
  • 4-Methoxy-N-ethylamphetamine (PMEA)
  • 4-Methoxy-N-methylamphetamine (PMMA)
  • 4-Methylthioamphetamine (4-MTA)
  • 5-(2-Aminopropyl)-2,3-dihydrobenzofuran (5-APDB)
  • 5-Indanyl-2-aminopropane (IAP)
  • 5-Methoxy-6-methylaminoindane (MMAI)
  • 5-Trifluoromethyl-2-aminoindane (TAI)
  • 5,6-Methylenedioxy-2-aminoindane (MDAI)
  • 5,6-Methylenedioxy-N-methyl-2-aminoindane (MDMAI)
  • 6-Chloro-2-aminotetralin (6-CAT)
  • 6-Tetralinyl-2-aminopropane (TAP)
  • 6,7-Methylenedioxy-2-aminotetralin (MDAT)
  • 6,7-Methylenedioxy-N-methyl-2-aminotetralin (MDMAT)
  • N-Ethyl-5-trifluoromethyl-2-aminoindane (ETAI)
  • N-Methyl-5-indanyl-2-aminopropane (IMP)

See also

  • Monoamine releasing agent

References

1. ^{{cite journal |vauthors=Marona-Lewicka D, Nichols DE | title = Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan | journal = European Journal of Pharmacology | volume = 258 | issue = 1–2 | pages = 1–13 |date=June 1994 | pmid = 7925587 | doi = 10.1016/0014-2999(94)90051-5| url = http://linkinghub.elsevier.com/retrieve/pii/0014-2999(94)90051-5| citeseerx = 10.1.1.688.1895 }}
2. ^{{cite journal |vauthors=Scorza C, Silveira R, Nichols DE, Reyes-Parada M | title = Effects of 5-HT-releasing agents on the extracellullar hippocampal 5-HT of rats. Implications for the development of novel antidepressants with a short onset of action | journal = Neuropharmacology | volume = 38 | issue = 7 | pages = 1055–61 |date=July 1999 | pmid = 10428424 | doi = 10.1016/S0028-3908(99)00023-4}}
3. ^{{cite journal |vauthors=Blough BE, Landavazo A, Decker AM, Partilla JS, Baumann MH, Rothman RB | title = Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes | journal = Psychopharmacology | volume = 231 | issue = 21 | pages = 4135–44 |date=October 2014 | pmid = 24800892 | doi = 10.1007/s00213-014-3557-7 | pmc=4194234}}

Further reading

{{refbegin}}
  • {{Cite journal |vauthors=Nichols DE, Marona-Lewicka D, Huang X, Johnson MP | title = Novel serotonergic agents | journal = Drug Design and Discovery | volume = 9 | issue = 3–4 | pages = 299–312 | year = 1993 | pmid = 8400010 | doi = | url = }}
  • {{Cite journal |vauthors=Marona-Lewicka D, Nichols DE | title = The Effect of Selective Serotonin Releasing Agents in the Chronic Mild Stress Model of Depression in Rats | journal = Stress (Amsterdam, Netherlands) | volume = 2 | issue = 2 | pages = 91–100 |date=December 1997 | pmid = 9787258 | doi = 10.3109/10253899709014740| url = }}
  • {{Cite journal |vauthors=Scorza C, Silveira R, Nichols DE, Reyes-Parada M | title = Effects of 5-HT-releasing agents on the extracellullar hippocampal 5-HT of rats. Implications for the development of novel antidepressants with a short onset of action | journal = Neuropharmacology | volume = 38 | issue = 7 | pages = 1055–61 |date=July 1999 | pmid = 10428424 | doi = 10.1016/S0028-3908(99)00023-4}}
  • {{Cite journal |vauthors=Rothman RB, Baumann MH | title = Serotonin releasing agents. Neurochemical, therapeutic and adverse effects | journal = Pharmacology Biochemistry and Behavior | volume = 71 | issue = 4 | pages = 825–36 |date=April 2002 | pmid = 11888573 | doi = 10.1016/S0091-3057(01)00669-4}}
{{refend}}{{Monoamine releasing agents}}{{TAAR ligands}}

3 : Serotonin releasing agents|TAAR1 agonists|VMAT inhibitors

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/9/26 2:21:21